Skip to content

Comparison of the effectiveness of the PLISSIT model with the Sexual health model on quality of life and sexual behavior among women with breast cancer

Comparison of the effectiveness of the PLISSIT model with the Sexual health model on quality of life and sexual behavior among women with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016083025431N2
Enrollment
75
Registered
2017-10-31
Start date
2016-09-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer. Malignant neoplasm: Overlapping lesion of breast

Interventions

The first group counseling wight PLISSIT model The second group counseling wight sexual health model The Third group control.
The first group counseling wight PLISSIT model The second group counseling wight sexual health model The Third group control

Sponsors

Zanjan university medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Study inclusion criteria: 1. Having a wife and sexually active individual reports 2. age between 20 and 50 years 3. Other breast cancer and non-cancer 4. Sexual Distress Scale score above 11 5. fiftieth percentile score means lower sexual behavior of women of reproductive age. 6. treatment of patients with surgery or chemotherapy or both  7. After at least 3 months of treatment, 8. do not receive formal education about sexual issues during the last 6 months 9. no history of mental illness in the past year at least 10. No drugs or alcohol Exclusion criteria Study: 1. relapse 2. intervention during hospitalization 3. Pregnancy 4. Start the field of psychiatric medications 5. participate in therapy sessions over a meeting

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sexual behavior/ quality of life. Timepoint: befor intervention/ 6 week after intervention/ 12 week after intervention. Method of measurement: DemoDemographic questionnaire, the questions related illness and treatments, native standardized questionnaire and sexual distress, sexual function questionnaire to determine the type of sexual dysfunction, native questionnaire to assess sexual behavior in women of childbearing age and quality of life questionnaire in patients with breast cancer.;Sexual behavior/ quality of life. Timepoint: befor intervention/ 6 week after intervention/ 12 week after intervention. Method of measurement: Demographic questionnaire, the questions related illness and treatments, native standardized questionnaire and sexual distress, sexual function questionnaire to determine the type of sexual dysfunction, native questionnaire to assess sexual behavior in women of childbearing age and quality of life questionnaire in patients with breast cancer.

Secondary

MeasureTime frame
Sexual Fanction. Timepoint: befor intrvention/ 6 week intervention/ 12 week intervention. Method of measurement: Femal sexual function scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEsmkhani Mina

Zanjan university medical science

minaesmkhani110@gmail.com+98 24 3355 1677

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026